Veracyte (VCYT) Tops Q1 EPS by 3c, Reiterates FY Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Veracyte Announces First Quarter 2015 Financial Results
May 14, 2015 4:05 PM EDTSOUTH SAN FRANCISCO, Calif., May 14, 2015 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT) today reported financial results for the first quarter ended March 31, 2015 and provided an update on recent business progress. For the first quarter of 2015, revenue was $11.2 million, an increase of 50%, compared to $7.5 million for the first quarter of 2014.
"Our results demonstrate continued execution on our strategy to increase the breadth and depth of Afirma® adoption across both community and institutional accounts," said Bonnie H. Anderson, Veracyte's president and... More
